On Monday shares of Invitae Corporation (NYSE:NVTA) closed at $15.40. Invitae Corp. (NYSE:NVTA) on 12 May, reported a loss of $18.6 million in its first quarter. The San Francisco-based company said it had a loss of $1.09 per share. TheRead More

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) in last trading activity increased 2.01% to close at $10.13. Company weekly performance is 4.00% while its quarterly performance stands at 45.13%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) is -51.62% away from its 52Read More

On Thursday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $9.93. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 10.27%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) onRead More

On Thursday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $9.93. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 10.27%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) willRead More

On Wednesday shares of YY Inc. (NASDAQ:YY) closed at $66.37. Company’s sales growth for last 5 years was 156.80% and EPS growth for next 5 years is recorded as 45.50%. YY Inc (NASDAQ:YY) on 11 May, reported first-quarter net incomeRead More

On Wednesday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A) closed at $9.22. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A) scandal looms large in Shell’s plan to buy BG Group. As Royal Dutch Shell seeks to finalise its £55bn takeover ofRead More

On Tuesday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $17.85. HC Wainright reiterated their buy rating on shares of Epizyme Inc. (NASDAQ:EPZM) in a research note released on 30 April. Cempra, Inc. (NASDAQ:CEMP) in last trading activity advanced 1.79% toRead More

On Tuesday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A) closed at $9.14. On 8 May, it was reported Petrobras Brasileiro Petrobras SA (ADR) (NYSE:PBR-A) informs that joined the Federal Prosecutors Office as principal in actions against a dishonest publicRead More

On Monday shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) closed at $10.70. Company’s sales growth for last 5 years was -15.60%. JPMorgan Chase & Co. reissued their overweight rating on shares of Keryx Biopharmaceuticals (NASDAQ:KERX) in a research report sent toRead More

On Monday shares of Gevo, Inc. (NASDAQ:GEVO) closed at $4.57. Company’s sales growth for last 5 years was 109.60% and EPS growth for next 5 years is recorded as 25.00%. Gevo, Inc. (NASDAQ:GEVO) announced on 7 May, that it hasRead More